Rheumatoid Arthritis (RA)Symptoms, Doctors, Treatments, Advances & More
Learn About Rheumatoid Arthritis (RA)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Westroads Clinic
Ted Mikuls is a Rheumatologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 25 years. Dr. Mikuls is rated as an Elite provider by MediFind in the treatment of Rheumatoid Arthritis (RA). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Rheumatoid Lung Disease, Knee Replacement, and Hip Replacement.
Internal Medicine Specialties At Durham Outpatient Center
Bryant England is a Rheumatologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 14 years. Dr. England is rated as an Elite provider by MediFind in the treatment of Rheumatoid Arthritis (RA). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Lung Disease, Rheumatoid Arthritis (RA), Arthritis, and Gout.
Internal Medicine Specialties At Durham Outpatient Center
James O'dell is a Rheumatologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 49 years. Dr. O'dell is rated as an Elite provider by MediFind in the treatment of Rheumatoid Arthritis (RA). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Gout, and Lupus Nephritis.
Summary: This is the first-in-human trial of MTS109 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS109 in moderate to severe autoimmune diseases.
Summary: To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.